Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009714

President and CEO sold 706 shares at $10.51 ($7,420)

From the SEC's structured data for this filing

Trades in this filing

AHMED NADIM · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-23 Sale : show line 1 in the form −706 $10.51 $7,420 118,004 D
Open-market sales · 706 sh · avg $10.51 · $7,420
Loading xslF345X04/doc4.xml…